Compare Alnylam Pharmaceuticals, Inc. (ALNY) vs FirstEnergy Corp. (FE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alnylam Pharmaceuticals, Inc. vs FirstEnergy Corp. — how do they compare? Alnylam Pharmaceuticals, Inc. trades at $220.35 (market cap $29.60B), while FirstEnergy Corp. trades at $46.86 (market cap $27.10B). The key difference: Alnylam Pharmaceuticals, Inc. and FirstEnergy Corp. are close in size by market cap, and FirstEnergy Corp. pays a 3.97% dividend while Alnylam Pharmaceuticals, Inc. pays none. Which is the better fit depends on your goals.
| ALNY | FE | |
|---|---|---|
Market Cap | $29.60B | $27.10B |
Sector | Health | Utilities |
52-Week High | $491.22 | $51.91 |
52-Week Low | $205.48 | $42.83 |
Enterprise Value | $27.56B | $56.02B |
Dividend Yield | — | 3.97% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia.
Read more on ALNY →About FirstEnergy Corp.
FirstEnergy is one of the largest investor-owned utilities in the United States with 10 regulated distribution companies across six mid-Atlantic and Midwestern states. FirstEnergy also owns and operates one of the nation's largest electric transmission systems with 24,000 miles of lines.
Read more on FE →
